Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hlscience Co. Ltd. (239610:KRX), powered by AI.
Hlscience Co. Ltd. is currently trading at ₩5,780. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Hlscience Co. Ltd. on Alpha Lenz.
Hlscience Co. Ltd.'s P/E ratio is -2.6.
“Hlscience Co. Ltd. trades at a P/E of -2.6 (undervalued) with modest ROE of -13.5%.”
Ask for details →Hlscience Co. Ltd. is a leading innovator in the nutraceutical and biotechnology industries, specializing in the research and development of functional health products. The company focuses on creating high-quality, scientifically-backed supplements and dietary products aimed at improving consumer health and wellness. Hlscience Co. Ltd. invests significantly in clinical research to validate the efficacy of its products, ensuring that their offerings meet stringent health standards and consumer expectations. Operating in a market driven by increasing health awareness and demand for preventive health measures, Hlscience Co. Ltd. serves a wide range of customers including health-conscious consumers, healthcare professionals, and wellness-oriented businesses. Their product range often includes sophisticated formulations targeting specific health conditions such as immune support, cognitive enhancement, and metabolic health. Hlscience Co. Ltd. holds a pivotal role in the growing global nutraceutical market, where the focus lies on innovation and efficacy. By leveraging advanced biotechnological processes, the company not only meets current health trends but also anticipates future needs, cementing its status as a leader in the health sciences sector.
“Hlscience Co. Ltd. trades at a P/E of -2.6 (undervalued) with modest ROE of -13.5%.”
Ask for details →Hlscience Co. Ltd. (ticker: 239610) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 71 employees. Market cap is $31.2B.
The current price is ₩5,780 with a P/E ratio of -2.62x and P/B of 0.38x.
ROE is -13.45% and operating margin is -66.15%. Annual revenue is $16.7B.